Global Buy the Dip

Chugai Pharmaceutical

Market Cap: JP¥13.5t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

DoorDash

Market Cap: US$77.8b

Operates a commerce platform that connects merchants, consumers, and independent contractors in the United States and internationally.

Fortinet

Market Cap: US$74.6b

Provides cybersecurity and convergence of networking and security solutions worldwide.

argenx

Market Cap: €30.3b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$32.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

BeiGene

Market Cap: US$25.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Summit Therapeutics

Market Cap: US$17.8b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

HOCHTIEF

Market Cap: €11.8b

Engages in the construction business worldwide.

Indian Hotels

Market Cap: ₹1.0t

Owns, operates, and manages hotels, palaces, and resorts in India and internationally.

Insmed

Market Cap: US$11.9b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Exelixis

Market Cap: US$10.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Akeso

Market Cap: HK$75.7b

A biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of antibody drugs.

Rocket Lab USA

Market Cap: US$9.5b

A space company, provides launch services and space systems solutions in the United States, Canada, Japan, and internationally.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$71.5b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Telix Pharmaceuticals

Market Cap: AU$9.1b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.

Verona Pharma

Market Cap: US$5.8b

A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.

TG Therapeutics

Market Cap: US$5.3b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

ADMA Biologics

Market Cap: US$4.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

WEILONG Delicious Global Holdings

Market Cap: HK$36.0b

Produces and sells spicy snack food in the People’s Republic of China and internationally.

3SBio

Market Cap: HK$28.5b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

Rhythm Pharmaceuticals

Market Cap: US$3.7b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Suzhou Zelgen BiopharmaceuticalsLtd

Market Cap: CN¥26.3b

Suzhou Zelgen Biopharmaceuticals Co.,Ltd.

MP Materials

Market Cap: US$3.6b

Produces rare earth materials in the Western Hemisphere.

SBI Sumishin Net Bank

Market Cap: JP¥518.7b

Provides various banking products and services to individuals and corporate customers in Japan.

GEO Group

Market Cap: US$3.5b

Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.

Compass

Market Cap: US$3.2b

Provides real estate brokerage services in the United States.

Oil and Gas Development

Market Cap: PK₨793.7b

Explores for, develops, produces, and sells oil and gas resources in Pakistan.

DeNA

Market Cap: JP¥404.4b

Develops and operates mobile and online services worldwide.

InnoCare Pharma

Market Cap: HK$20.3b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Shanghai Henlius Biotech

Market Cap: HK$19.2b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

Peloton Interactive

Market Cap: US$2.5b

Operates integrated fitness platform in North America and internationally.

Truecaller

Market Cap: SEK 22.6b

Engages in developing and publishing mobile caller ID applications for individuals and business in India, the Middle East, Africa, and internationally.

Hesai Group

Market Cap: US$2.2b

Through with its subsidiaries, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally.

Better Life Commercial Chain ShareLtd

Market Cap: CN¥15.1b

Engages in retail merchandise business in China.

BioCryst Pharmaceuticals

Market Cap: US$2.1b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Storskogen Group

Market Cap: SEK 18.4b

Owns and develops small and medium-sized businesses operating in services, trade, and industrial sectors.